Letter in response to Cole-Hunter et al., 2023: What does "Parkinson's disease mortality" mean?

dc.contributor.authorRumrich Isabell Katharina
dc.contributor.authorKaasinen Valtteri
dc.contributor.authorHänninen Otto
dc.contributor.authorHartikainen Sirpa
dc.contributor.authorTolppanen Anna-Maija
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.74845969893
dc.converis.publication-id179266521
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179266521
dc.date.accessioned2025-08-27T23:39:02Z
dc.date.available2025-08-27T23:39:02Z
dc.identifier.eissn1873-6750
dc.identifier.jour-issn0160-4120
dc.identifier.olddbid204361
dc.identifier.oldhandle10024/187388
dc.identifier.urihttps://www.utupub.fi/handle/11111/52563
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0160412023001253?via%3Dihub
dc.identifier.urnURN:NBN:fi-fe2023042137991
dc.language.isoen
dc.okm.affiliatedauthorKaasinen, Valtteri
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeB1 Scientific Journal
dc.publisherPergamon-Elsevier Science Ltd
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.articlenumber107852
dc.relation.doi10.1016/j.envint.2023.107852
dc.relation.ispartofjournalEnvironment International
dc.relation.volume173
dc.source.identifierhttps://www.utupub.fi/handle/10024/187388
dc.titleLetter in response to Cole-Hunter et al., 2023: What does "Parkinson's disease mortality" mean?
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0160412023001253-main.pdf
Size:
307.22 KB
Format:
Adobe Portable Document Format